Ipsen And Foreseen Biotechnology Strike Deal For FS001, Antibody-Drug Conjugate

view original post

(RTTNews) – Ipsen (IPSEY) and Foreseen Biotechnology have entered into an exclusive global licensing agreement for FS001, an antibody-drug conjugate or ADC with first-in-class potential. FS001 targets …